BizStats
You are here: bizstats.co.uk > a-z index > P list > PU list > PUL list

Pulmagen Therapeutics (inflammation) Limited LONDON

Pulmagen Therapeutics (Inflammation) Limited was dissolved on 2021-10-12. Pulmagen Therapeutics (inflammation) was a private limited company that was located at 30 C/O Mvm Partners Llp, 30 St. George Street, London, W1S 2FH, ENGLAND. The company (officially started on 2009-11-26) was run by 7 directors and 1 secretary.
Director Stephen R. who was appointed on 23 March 2012.
Director Harry F. who was appointed on 29 January 2010.
Director Hugo S. who was appointed on 29 January 2010.
Moving on to the secretaries, we can name: Colin K. appointed on 11 January 2010.

The company was officially classified as "other research and experimental development on natural sciences and engineering" (72190). As stated in the Companies House database, there was a name change on 2010-02-16 and their previous name was Argenta Therapeutics. There is a second name alteration mentioned: previous name was Continental Shelf 487 performed on 2010-01-14. The most recent confirmation statement was sent on 2020-11-26 and last time the annual accounts were sent was on 30 September 2020. 2015-11-26 was the date of the last annual return.

Pulmagen Therapeutics (inflammation) Limited Address / Contact

Office Address 30 C/o Mvm Partners Llp
Office Address2 30 St. George Street
Town London
Post code W1S 2FH
Country of origin United Kingdom

Company Information / Profile

Registration Number 07087533
Date of Incorporation Thu, 26th Nov 2009
Date of Dissolution Tue, 12th Oct 2021
Industry Other research and experimental development on natural sciences and engineering
End of financial Year 30th September
Company age 12 years old
Account next due date Thu, 30th Jun 2022
Account last made up date Wed, 30th Sep 2020
Next confirmation statement due date Fri, 10th Dec 2021
Last confirmation statement dated Thu, 26th Nov 2020

Company staff

Stephen R.

Position: Director

Appointed: 23 March 2012

Harry F.

Position: Director

Appointed: 29 January 2010

Hugo S.

Position: Director

Appointed: 29 January 2010

Ian K.

Position: Director

Appointed: 29 January 2010

Mary F.

Position: Director

Appointed: 29 January 2010

Colin K.

Position: Secretary

Appointed: 11 January 2010

Christopher A.

Position: Director

Appointed: 11 January 2010

Colin K.

Position: Director

Appointed: 11 January 2010

Martin M.

Position: Director

Appointed: 29 January 2010

Resigned: 23 March 2012

Md Secretaries Limited

Position: Corporate Secretary

Appointed: 26 November 2009

Resigned: 11 January 2010

Patrick M.

Position: Director

Appointed: 26 November 2009

Resigned: 11 January 2010

Md Directors Limited

Position: Director

Appointed: 26 November 2009

Resigned: 11 January 2010

People with significant control

Mvm Life Science Partners Limited Liability Partnership

6 Henrietta Street, London, WC2E 8PU, England

Legal authority Limited Liability Partnerships Act 2000
Legal form Limited Liability Partnership
Country registered England
Place registered Companies House
Registration number Oc311719
Notified on 6 April 2016
Nature of control: significiant influence or control

Company previous names

Argenta Therapeutics February 16, 2010
Continental Shelf 487 January 14, 2010

Company filings

Filing category
Accounts Address Annual return Capital Change of name Confirmation statement Dissolution Gazette Incorporation Insolvency Officers Resolution
Total exemption full accounts record for the accounting period up to Wednesday 30th September 2020
filed on: 10th, March 2021 		Free Download (16 pages)

Company search

Companies nearby - by postcode

© bizstats.co.uk 2024.

Terms of Use and Privacy Policy
Contains public sector information licensed under the Open Government Licence v2.0.

Contact us

Email: info@bizstats.co.uk
All the information provided is derived from publicly available records. Unintentional errors are possible - bizstats.co.uk is not responsible for how accurate or up to date the data is. You use the information provided at your own risk.